Bin Liu

Institution
National University of Singapore

Country
Singapore

Field
Materials Sciences

Liu was awarded the 2024 President’s Science Award for her discovery of the role of carbazole isomers in room temperature phosphorescence of carbazole and subsequent revelation of the transformative impact of isostructural doping on the optical properties of organic semiconductors, opening new avenues of study and application. She specializes in bringing organic semiconductors into aqueous media, with a focus on the exploration of their unique applications in biomedical research, security and electronic devices.

In recent years, she has worked on biocompatible luminogens that serve as highly sensitive light-up molecular probes and nanoparticle probes, opening up new horizons for non-invasive tracking of analytes and biological processes in real time. Liu is also passionate about nurturing the next generation research leaders and encouraging more women to pursue careers in engineering and science.

 

(Photo: National University of Singapore)

AWARDS
  • 2024 President’s Science Award

Related articles

New Materials Reach Record Efficiencies

Affordable and efficient solar power is now one step closer to reality with the ability to control polymer morphology via temperature.

The Link Between Nickel Exposure And Diabetes

Exposure to the heavy metal nickel is associated with the development of Type 2 diabetes.

How Slime Mold Move Long Distances

A study of how slime molds sense direction could lead to a better understanding of wound healing and immune cell migration in humans.

How Working Memory Works

Scientists at the Shanghai Institutes for Biological Sciences have pinpointed the brain region involved in working memory in mice.

Complex Jujube Genome Successfully Sequenced

The sequencing of the jujube genome could lead to a better understanding of the genetic basis of its resistance to high salinity, drought and alkaline conditions.

China To Spend US$308.5 Billion On Biotechnology Over Five Years

China will spend two trillion yuan (US$308.5 billion) on science and technology in the next five years, making biotechnology a priority.

China Sky One Medical To Carry Out Human Stem Cell Research

Chinese pharma China Sky One Medical, Inc.'s subsidiary will jointly set up a new company, Harbin Tian Xin Biological Engineering Ltd, to use adult human stem cells in clinical applications.

SABIC Invests US$100 Million Into New R&D Hub In Shanghai, China

Saudi Basic Industries Corporation will invest US$100 million into a new research & development hub in Kangqiao, east of Shanghai, China.

First Circulating Tumor Cell Test Approved In China

A new circulating tumor cell test for metastatic breast cancer has been approved by the China SFDA.